Metoprolol Zentiva

Metoprolol Tartrate, the active ingredient in Metoprolol Zentiva, is a beta blocker presented as an oral tablet for oral use. It lowers blood pressure and reduces cardiac workload in adults with hypertension, angina, or other cardiovascular conditions.

GNH USA supplies Metoprolol Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable logistics for global distribution. Our network ensures timely delivery and regulatory support across multiple regions. We also offer technical assistance for product integration.

Metoprolol Zentiva is a selective β1‑adrenergic blocker used in several cardiovascular conditions. - Hypertension: reduces systolic and diastolic blood pressure, helping to prevent cardiovascular complications. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain during exertion. - Heart failure: improves left ventricular function and reduces hospitalizations in chronic heart failure patients. - Post‑myocardial infarction prophylaxis: lowers risk of recurrent ischemic events and arrhythmias after an MI. - Cardiac arrhythmias: controls ventricular rate in atrial fibrillation and other supraventricular tachyarrhythmias.

Metoprolol Zentiva may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Bradycardia (slow heart rate) - Cold extremities - Gastrointestinal upset (nausea, abdominal discomfort) - Headache

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm in susceptible individuals - Allergic reactions (rash, angioedema) - Depression or mood changes

Before initiating therapy, clinicians should consider several safety measures. - Cardiac assessment: evaluate baseline heart rate and rhythm. - Monitor blood pressure and heart rate regularly during treatment. - Caution in asthma or COPD: β1‑selectivity may still affect bronchial tone. - Dose adjustment: consider renal or hepatic impairment when titrating. - Avoid abrupt discontinuation: taper gradually to prevent rebound hypertension. - Store at ambient temperature: keep in the original pack, protect from moisture.

Metoprolol Zentiva can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Other AV‑nodal blockers (e.g., verapamil, diltiazem) may cause excessive bradycardia. - Clonidine withdrawal can precipitate hypertensive crisis if metoprolol is stopped abruptly. - Insulin or oral hypoglycemics: metoprolol may mask hypoglycemia symptoms.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) can increase metoprolol plasma levels. - NSAIDs may reduce the antihypertensive effect of metoprolol.